JP2008522955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008522955A5 JP2008522955A5 JP2007526862A JP2007526862A JP2008522955A5 JP 2008522955 A5 JP2008522955 A5 JP 2008522955A5 JP 2007526862 A JP2007526862 A JP 2007526862A JP 2007526862 A JP2007526862 A JP 2007526862A JP 2008522955 A5 JP2008522955 A5 JP 2008522955A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- ylthio
- pitavastatin
- benzimidazol
- piperazin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003937 drug carrier Substances 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- VGYFMXBACGZSIL-MCBHFWOFSA-N pitavastatin Chemical compound OC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-MCBHFWOFSA-N 0.000 claims 12
- 229960002797 pitavastatin Drugs 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 150000004677 hydrates Chemical class 0.000 claims 10
- VGGMTOYKEDKFLN-UHFFFAOYSA-N 2-[4-[2-(1h-benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-n-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide Chemical compound CSC1=CC(C)=NC(SC)=C1NC(=O)CN1CCN(CCSC=2NC3=CC=CC=C3N=2)CC1 VGGMTOYKEDKFLN-UHFFFAOYSA-N 0.000 claims 9
- 230000003143 atherosclerotic effect Effects 0.000 claims 8
- 230000003902 lesion Effects 0.000 claims 8
- 150000002632 lipids Chemical class 0.000 claims 8
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 6
- 208000004476 Acute Coronary Syndrome Diseases 0.000 claims 4
- 206010002388 Angina unstable Diseases 0.000 claims 4
- 208000031104 Arterial Occlusive disease Diseases 0.000 claims 4
- 208000007536 Thrombosis Diseases 0.000 claims 4
- 208000007814 Unstable Angina Diseases 0.000 claims 4
- 206010000891 acute myocardial infarction Diseases 0.000 claims 4
- 208000021328 arterial occlusion Diseases 0.000 claims 4
- 230000015572 biosynthetic process Effects 0.000 claims 4
- 230000002708 enhancing effect Effects 0.000 claims 4
- 201000004332 intermediate coronary syndrome Diseases 0.000 claims 4
- 230000002093 peripheral effect Effects 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- -1 Benzimidazol-2-ylthio Chemical group 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 3
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000000069 prophylactic effect Effects 0.000 claims 2
- 230000006641 stabilisation Effects 0.000 claims 2
- 238000011105 stabilization Methods 0.000 claims 2
- 230000000087 stabilizing effect Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63453204P | 2004-12-10 | 2004-12-10 | |
| PCT/JP2005/023088 WO2006064889A1 (en) | 2004-12-10 | 2005-12-09 | Method for reduction, stabilization and prevention of rupture of lipid rich plaque |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008522955A JP2008522955A (ja) | 2008-07-03 |
| JP2008522955A5 true JP2008522955A5 (enExample) | 2008-10-16 |
Family
ID=36587943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526862A Pending JP2008522955A (ja) | 2004-12-10 | 2005-12-09 | リピド・リッチ・プラークの縮小、安定化及び破裂予防方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20090275595A1 (enExample) |
| EP (1) | EP1827440A4 (enExample) |
| JP (1) | JP2008522955A (enExample) |
| KR (1) | KR100895031B1 (enExample) |
| CN (1) | CN101068548B (enExample) |
| AU (1) | AU2005314810B2 (enExample) |
| CA (1) | CA2590224C (enExample) |
| NZ (1) | NZ554924A (enExample) |
| RU (1) | RU2351337C1 (enExample) |
| TW (1) | TW200619204A (enExample) |
| WO (1) | WO2006064889A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060111898A (ko) * | 2003-08-29 | 2006-10-30 | 교와 가부시키가이샤 | 지질-풍부-플라크의 안정화 방법 및 파열 예방방법 |
| US8048083B2 (en) * | 2004-11-05 | 2011-11-01 | Dfine, Inc. | Bone treatment systems and methods |
| WO2011081118A1 (ja) * | 2009-12-29 | 2011-07-07 | 興和株式会社 | 経口投与用医薬組成物 |
| CN102711762A (zh) * | 2009-12-29 | 2012-10-03 | 兴和株式会社 | 口服用固体医药组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444784A (en) * | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| MX7065E (es) * | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| JP2569746B2 (ja) * | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | キノリン系メバロノラクトン類 |
| US5177080A (en) * | 1990-12-14 | 1993-01-05 | Bayer Aktiengesellschaft | Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| CZ127198A3 (cs) * | 1995-11-02 | 1998-12-16 | Warner-Lambert Company | Způsob regulace koncentrace lipidů a farmaceutická kompozice pro tento způsob |
| US6969711B2 (en) * | 1997-05-26 | 2005-11-29 | Kowa Company, Ltd. | Cyclic diamine compounds and medicine containing the same |
| HUP0002294A3 (en) * | 1997-05-26 | 2001-10-29 | Kowa Co | Cyclic diamine compounds and medicines containing the same |
| RU2235483C2 (ru) * | 1998-11-25 | 2004-09-10 | Нутри Фарма Аса | Композиция, фармацевтический препарат и способ для профилактики и/или лечения и/или ослабления сердечно-сосудистых заболеваний |
| WO2001022962A1 (en) * | 1999-09-30 | 2001-04-05 | Merck & Co., Inc. | Anti-hypercholesterolemic drug combination |
| US6974806B2 (en) * | 2000-07-13 | 2005-12-13 | Takeda Pharmaceutical Company Limited | Lipid-rich plaque inhibitors |
| AU8254101A (en) * | 2000-09-01 | 2002-03-22 | Sankyo Co | Medicinal compositions |
| US20060165605A1 (en) * | 2001-12-28 | 2006-07-27 | Ye-Mon Chen | Process to regenerate fcc spent catalyst |
| MY140618A (en) * | 2003-02-28 | 2009-12-31 | Kowa Co | Method for preparing acid addition salts of polyacidic basic compounds |
| US20060046996A1 (en) * | 2004-08-31 | 2006-03-02 | Kowa Co., Ltd. | Method for treating hyperlipidemia |
-
2005
- 2005-11-01 TW TW094138206A patent/TW200619204A/zh unknown
- 2005-12-09 CA CA2590224A patent/CA2590224C/en not_active Expired - Fee Related
- 2005-12-09 US US11/721,402 patent/US20090275595A1/en not_active Abandoned
- 2005-12-09 CN CN2005800416162A patent/CN101068548B/zh not_active Expired - Fee Related
- 2005-12-09 KR KR1020077012071A patent/KR100895031B1/ko not_active Expired - Fee Related
- 2005-12-09 JP JP2007526862A patent/JP2008522955A/ja active Pending
- 2005-12-09 AU AU2005314810A patent/AU2005314810B2/en not_active Ceased
- 2005-12-09 NZ NZ554924A patent/NZ554924A/en not_active IP Right Cessation
- 2005-12-09 WO PCT/JP2005/023088 patent/WO2006064889A1/en not_active Ceased
- 2005-12-09 RU RU2007125976/15A patent/RU2351337C1/ru not_active IP Right Cessation
- 2005-12-09 EP EP05816536A patent/EP1827440A4/en not_active Withdrawn
-
2011
- 2011-04-28 US US13/096,477 patent/US20110207742A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015528471A5 (enExample) | ||
| JP2015512406A5 (enExample) | ||
| JP2024540183A5 (enExample) | ||
| JP2006508953A5 (enExample) | ||
| JP2018168191A5 (enExample) | ||
| JP2004512328A5 (enExample) | ||
| JP2002528502A5 (enExample) | ||
| ES2489265T3 (es) | Asociación de inhibidores de la HMG-CoA reductasa atorvastatina o simvastatina con un inhibidor de la fosfodiesterasa 4, tal como roflumilast para el tratamiento de enfermedades pulmonares inflamatorias | |
| JP2006514100A5 (enExample) | ||
| JP2012524092A5 (enExample) | ||
| JP2009513713A5 (enExample) | ||
| JP2007532607A5 (enExample) | ||
| JP2009062388A5 (enExample) | ||
| JP2023530120A5 (enExample) | ||
| TWI351950B (en) | Use of (halobenzyloxy) benzylamino-propanamides fo | |
| JP2005508963A5 (enExample) | ||
| JP2005513014A5 (enExample) | ||
| RU2014112324A (ru) | Применение органического соединения для лечения синдрома нунан | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| CA2590224A1 (en) | Method for reduction, stabilization and prevention of rupture of lipid rich plaque | |
| JP2024500632A5 (enExample) | ||
| JP4839309B2 (ja) | 血栓症治療剤 | |
| CA2535920A1 (en) | Method of stabilizing lipid-rich plaque and method of preventing rupture thereof | |
| JP2007514699A5 (enExample) |